Ontvang nu dagelijks onze kooptips!
word abonnee
sluiten ✕
eind van de maand, 10-12 pond,
Ik verwacht eerder naar de 14 ---- 15 pond naar de eerdere koers en dan verder omhoog indien de omzet blijft stijgen
Ik ben wat voorzichtiger, en eerst maar weer eens door die 10 pond heen komen. Wat wel duidelijk is natuurlijk dat veel grote beleggings maatschappijen vertrouwen hebben in Sopheon, anders koop je geen aandelen aan. Dus op naar 23 Maart met hopenlijk een mooie outlook voor 2021.
Gartje schreef op 4 maart 2021 19:28 :
Wat wel duidelijk is natuurlijk dat veel grote beleggingsmaatschappijen vertrouwen hebben in Sopheon, anders koop je geen aandelen aan.
Hoor ik daar "een kwartje" vallen?? *_*Bertus S.
lekker hoog volume de afgelopen 2 dagen, waar waren de door het management verkochte aandelen ook al weer voor nodig?
Geen beweging in te krijgen, maar wel terug van 10 pond naar 8,60. Gelukkig hebben we de drank nog;-))
volgende week weten we meer, zie dat de vacatures ook verminderd zijn.
Wie trekt er even aan de bel bij Sopheon! Lijkt wel of dat ze in slaap zijn gevallen. Een freeze waar je als aandeelhouder niet op zit te wachten!
Een vraagje aan trinko wat is jou visie over sopheon
Zoals jullie weten ,heb ik het geluk gehad om al mijn aandelen in Sopheon te verkopen rond hun ATH. Op dat moment vond ik the K/W verhouding niet meer in verhouding staan t.o.v hun groei! Ben ook Noot meer ingestapt ook niet op 5, Mijn mening is dat Sopheon een goed bedrijf is, aangezien the omstandigheden van, zeg de laatste 15 maanden.. Ze maken ongeveer de zelfde winst als vorige jaar.( Cijfers zijn net uit) Maar het dividend rendement is te laag om in te stappen. Naar mijn mening doen ze te weinig met hun excellent gevulde kas! Dus in mijn ogen zijn er 1 reden om weer in te stappen, als ze een overname doen wat de groei weer aanzwengelt. Aangezien ik dit al jaren verwachtt en gebeurt niet , daarbij de aandelen verkoop op 9 euro doen mij niet hoopgevend stemmen. Het beste voor de huidige aandeelhouders zou een overname zijn! Maar dan ben ik te laat! Conclusie voor mij; dood geld voor te time being en alleen een overname door Sopheon zou mijn interesse weer wekken. Voor jullie een overname van Sopheon. Suc6 allemaal . Groet trinko
Hier nog even de samenvatting:Audited Results Statement for the Year to 31 December 202 0 Sopheon plc, the international provider of software, expertise, and best practices for Enterprise Innovation Performance, is pleased to announce its results for the year ended 31 December 2020, in line with market expectations, together with an outlook for the current year.Financial Highlights: Revenue of $30.0m, maintained in the face of challenging year due to COVID, whilst embarking on a SaaS transition (2019: $30.3m) ARR1 rose from $15.9m at the start of 2020 to $18.0m at the end of the year Full year 2021 revenue visibility2 is now at $24.5m (last year at this time: $21.2m) TCV2 of signed contract bookings up 1.25X, and TCV of SaaS bookings up 2.74X Adjusted EBITDA3 of $5.9m (2019: $6.4m) PBT of $1.7m (2019: $2.5m) Net cash of $21.7m (2019: $19.4m) and the Group has no debt Dividend to be maintained at 3.25p per share (2019: 3.25p)Operational Highlights 10 new customer wins including DuPont, LG, Hochland, Clif Bar and Mondelez. Six of the new customers signed had deal values over $1m. SaaS First and SaaS uplift programs introduced to assist clients in moving to the cloud. Over 50% of new clients signed SaaS contracts and four existing clients converted to SaaS as part of the SaaS Uplift program. Continued investment in cloud-native SaaS capabilities for Accolade Gross retention of 91.5% (2019: 94.2%) with customers taking cost decisions earlier in the year, with a return to improved levels in the second half Greg Coticchia, who has been working with us for some time and demonstrated his capability and value add to the Group, to join Board and spearhead cloud strategy as CEO. Andy Michuda to become Executive Chairman, focusing on partnerships and M&A alongside governance. Barry Mence to step down to become a Non-Executive Director.Barry Mence, Chairman, commented: “With a solid revenue base already in place for 2021, plus our strong balance sheet, a superb customer base and a team of great people – I am confident that Sopheon has a great future, and that the SaaS transition is exactly the right strategy to pursue. The board is excited to be appointing Greg Coticchia as CEO – he is already having significant impact on the business, and his experience and track record in software and innovation are invaluable. I can think of no better person than Andy Michuda for the role of Executive Chairman. My own commitment to Sopheon is undimmed, and I will remain a non-executive director and major shareholder in the company as we go through this exciting new chapter in the Sopheon story. We also continue to believe in sharing success with shareholders, and I am therefore pleased to announce that we will again maintain our dividend at 3.25p per share.” For further information contact: Barry Mence (Chairman) Arif Karimjee (CFO) Sopheon plc + 44 (0) 1276 919 560Bertus S.
Paniekjaar 2020 zo afsluiten + hoogste visibility ooit. Ik vind het knap. Groet ABC.
Eens abc, maar als ik Mence lees dan wil hij wat terug doen voor de aandeelhouders, met zijn 3:25 per aandeel, gezien zijn greep in de kas had 5 pence een goed signaal geweest naar de toekomst en de cijfers voor 2021 voor de trouwe aandeelhouders!!
dank trinko voor je reactie
trinko schreef op 24 maart 2021 11:16 :
Graag gedaan!
bamboo de 2de
abc123xyz987 schreef op 24 maart 2021 09:19 :
Paniekjaar 2020 zo afsluiten + hoogste visibility ooit. Ik vind het knap.
Groet ABC.
eens, dividend na zn wereldwijde pandemie die nog heerst, en hochland is ook geen klein klantje.
Sopheon Names Greg Coticchia Chief Executive Officer Experienced Tech Leader to Drive Growth of Sopheon’s SaaS-based Enterprise Innovation Management Platform MINNEAPOLIS –March 24, 2021 – Sopheon (LSE: SPE) today announced the appointment of Greg Coticchia to the position of Chief Executive Officer (CEO), effective on March 31, 2021. As part of this planned transition strategy, Andy Michuda will become Executive Chairman of Sopheon’s Board of Directors. Barry Mence, who has been Chairman of the Board since the company’s inception, will serve as a non-executive director of Sopheon and remain a major investor in the company. Coticchia, who joined Sopheon as President in 2020, will also take a seat on the board of directors. With deep experience in the creation and growth of SaaS companies, Coticchia is an award-winning entrepreneur, business strategist, product manager and marketing expert. Coticchia will spearhead Sopheon’s growth as the industry’s most versatile and powerful enterprise innovation management cloud platform. Michuda will focus on partnerships and acquisitions, in addition to his governance responsibilities as Executive Chairman. “Digital transformation continues to accelerate, and innovation is an urgent imperative for virtually every company,” said Coticchia. “But fostering and governing innovation can be difficult in large organizations with diverse methodologies and siloed teams. Sopheon has a large opportunity to build upon its success at hundreds of companies worldwide to drive— and keep—innovation moving forward aggressively while still delivering resilient and reliable product experiences." “We welcome Greg to Sopheon’s board of directors and look forward to his creative and energetic leadership as CEO,” said Mence, a co-founder of Sopheon. “Greg is a highly-regarded entrepreneur, business leader, professor and author. His impressive experience in leading strategic transitions in the SaaS industry is an ideal fit as we continue to grow our popular SaaS-based offerings.” Accolade is Sopheon’s innovation management platform. Accolade enables businesses to operate with more agility and responsiveness. By creating cross-functional collaboration and synchronization, Accolade connects people, systems and information across departments and functions. This results in faster time to market, increased product success and reduced costs. Accolade has proven its value to thousands of global users, such as PepsiCo, P&G, Merck KgaA, Mondelez, BASF, Parker Hannifin and other innovation and market leaders across a wide variety of industries. For more information about how Sopheon is transforming enterprise innovation, visit our website at www.sopheon.com. Sopheon released financial results for 2020 earlier today. The annual report can be viewed at www.sopheon.com/financial-reports.
Aantal posts per pagina:
20
50
100
Direct naar Forum
-- Selecteer een forum --
Koffiekamer
Belastingzaken
Beleggingsfondsen
Beursspel
BioPharma
Daytraders
Garantieproducten
Opties
Technische Analyse
Technische Analyse Software
Vastgoed
Warrants
10 van Tak
4Energy Invest
Aalberts
AB InBev
Abionyx Pharma
Ablynx
ABN AMRO
ABO-Group
Acacia Pharma
Accell Group
Accentis
Accsys Technologies
ACCSYS TECHNOLOGIES PLC
Ackermans & van Haaren
ADMA Biologics
Adomos
AdUX
Adyen
Aedifica
Aegon
AFC Ajax
Affimed NV
ageas
Agfa-Gevaert
Ahold
Air France - KLM
Airspray
Akka Technologies
AkzoNobel
Alfen
Allfunds Group
Allfunds Group
Almunda Professionals (vh Novisource)
Alpha Pro Tech
Alphabet Inc.
Altice
Alumexx ((Voorheen Phelix (voorheen Inverko))
AM
Amarin Corporation
Amerikaanse aandelen
AMG
AMS
Amsterdam Commodities
AMT Holding
Anavex Life Sciences Corp
Antonov
Aperam
Apollo Alternative Assets
Apple
Arcadis
Arcelor Mittal
Archos
Arcona Property Fund
arGEN-X
Aroundtown SA
Arrowhead Research
Ascencio
ASIT biotech
ASMI
ASML
ASR Nederland
ATAI Life Sciences
Atenor Group
Athlon Group
Atrium European Real Estate
Auplata
Avantium
Axsome Therapeutics
Azelis Group
Azerion
B&S Group
Baan
Ballast Nedam
BALTA GROUP N.V.
BAM Groep
Banco de Sabadell
Banimmo A
Barco
Barrick Gold
BASF SE
Basic-Fit
Basilix
Batenburg Beheer
BE Semiconductor
Beaulieulaan
Befimmo
Bekaert
Belgische aandelen
Beluga
Beter Bed
Bever
Binck
Biocartis
Biophytis
Biosynex
Biotalys
Bitcoin en andere cryptocurrencies
bluebird bio
Blydenstijn-Willink
BMW
BNP Paribas S.A.
Boeing Company
Bols (Lucas Bols N.V.)
Bone Therapeutics
Borr Drilling
Boskalis
BP PLC
bpost
Brand Funding
Brederode
Brill
Bristol-Myers Squibb
Brunel
C/Tac
Campine
Canadese aandelen
Care Property Invest
Carmila
Carrefour
Cate, ten
CECONOMY
Celyad
CFD's
CFE
CGG
Chinese aandelen
Cibox Interactive
Citygroup
Claranova
CM.com
Co.Br.Ha.
Coca-Cola European Partners
Cofinimmo
Cognosec
Colruyt
Commerzbank
Compagnie des Alpes
Compagnie du Bois Sauvage
Connect Group
Continental AG
Corbion
Core Labs
Corporate Express
Corus
Crescent (voorheen Option)
Crown van Gelder
Crucell
CTP
Curetis
CV-meter
Cyber Security 1 AB
Cybergun
D'Ieteren
D.E Master Blenders 1753
Deceuninck
Delta Lloyd
DEME
Deutsche Cannabis
DEUTSCHE POST AG
Dexia
DGB Group
DIA
Diegem Kennedy
Distri-Land Certificate
DNC
Dockwise
DPA Flex Group
Draka Holding
DSC2
DSM
Duitse aandelen
Dutch Star Companies ONE
Duurzaam Beleggen
DVRG
Ease2pay
Ebusco
Eckert-Ziegler
Econocom Group
Econosto
Edelmetalen
Ekopak
Elastic N.V.
Elia
Endemol
Energie
Energiekontor
Engie
Envipco
Erasmus Beursspel
Eriks
Esperite (voorheen Cryo Save)
EUR/USD
Eurobio
Eurocastle
Eurocommercial Properties
Euronav
Euronext
Euronext
Euronext.liffe Optiecompetitie
Europcar Mobility Group
Europlasma
EVC
EVS Broadcast Equipment
Exact
Exmar
Exor
Facebook
Fagron
Fastned
Fingerprint Cards AB
First Solar Inc
FlatexDeGiro
Floridienne
Flow Traders
Fluxys Belgium D
FNG (voorheen DICO International)
Fondsmanager Gezocht
ForFarmers
Fountain
Frans Maas
Franse aandelen
FuelCell Energy
Fugro
Futures
FX, Forex, foreign exchange market, valutamarkt
Galapagos
Gamma
Gaussin
GBL
Gemalto
General Electric
Genfit
Genmab
GeoJunxion
Getronics
Gilead Sciences
Gimv
Global Graphics
Goud
GrandVision
Great Panther Mining
Greenyard
Grolsch
Grondstoffen
Grontmij
Guru
Hagemeyer
HAL
Hamon Groep
Hedge funds: Haaien of helden?
Heijmans
Heineken
Hello Fresh
HES Beheer
Hitt
Holland Colours
Homburg Invest
Home Invest Belgium
Hoop Effektenbank, v.d.
Hunter Douglas
Hydratec Industries (v/h Nyloplast)
HyGear (NPEX effectenbeurs)
HYLORIS
Hypotheken
IBA
ICT Automatisering
Iep Invest (voorheen Punch International)
Ierse aandelen
IEX Group
IEX.nl Sparen
IMCD
Immo Moury
Immobel
Imtech
ING Groep
Innoconcepts
InPost
Insmed Incorporated (INSM)
IntegraGen
Intel
Intertrust
Intervest Offices & Warehouses
Intrasense
InVivo Therapeutics Holdings Corp (NVIV)
Isotis
JDE PEET'S
Jensen-Group
Jetix Europe
Johnson & Johnson
Just Eat Takeaway
Kardan
Kas Bank
KBC Ancora
KBC Groep
Kendrion
Keyware Technologies
Kiadis Pharma
Kinepolis Group
KKO International
Klépierre
KPN
KPNQwest
KUKA AG
La Jolla Pharmaceutical
Lavide Holding (voorheen Qurius)
LBC
LBI International
Leasinvest
Logica
Lotus Bakeries
Macintosh Retail Group
Majorel
Marel
Mastrad
Materialise NV
McGregor
MDxHealth
Mediq
Melexis
Merus Labs International
Merus NV
Microsoft
Miko
Mithra Pharmaceuticals
Montea
Moolen, van der
Mopoli
Morefield Group
Mota-Engil Africa
MotorK
Moury Construct
MTY Holdings (voorheen Alanheri)
Nationale Bank van België
Nationale Nederlanden
NBZ
Nedap
Nedfield
Nedschroef
Nedsense Enterpr
Nel ASA
Neoen SA
Neopost
Neovacs
NEPI Rockcastle
Netflix
New Sources Energy
Neways Electronics
NewTree
NexTech AR Solutions
NIBC
Nieuwe Steen Investments
Nintendo
Nokia
Nokia OYJ
Nokia Oyj
Novacyt
NOVO-NORDISK AS
NPEX
NR21
Numico
Nutreco
Nvidia
NWE Nederlandse AM Hypotheek Bank
NX Filtration
NXP Semiconductors NV
Nyrstar
Nyxoah
Océ
OCI
Octoplus
Oil States International
Onconova Therapeutics
Ontex
Onward Medical
Onxeo SA
OpenTV
OpGen
Opinies - Tilburg Trading Club
Opportunty Investment Management
Orange Belgium
Oranjewoud
Ordina Beheer
Oud ForFarmers
Oxurion (vh ThromboGenics)
P&O Nedlloyd
PAVmed
Payton Planar Magnetics
Perpetuals, Steepeners
Pershing Square Holdings Ltd
Personalized Nursing Services
Pfizer
Pharco
Pharming
Pharnext
Philips
Picanol
Pieris Pharmaceuticals
Plug Power
Politiek
Porceleyne Fles
Portugese aandelen
PostNL
Priority Telecom
Prologis Euro Prop
ProQR Therapeutics
PROSIEBENSAT.1 MEDIA SE
Prosus
Proximus
Qrf
Qualcomm
Quest For Growth
Rabobank Certificaat
Randstad
Range Beleggen
Recticel
Reed Elsevier
Reesink
Refresco Gerber
Reibel
Relief therapeutics
Renewi
Rente en valuta
Resilux
Retail Estates
RoodMicrotec
Roularta Media
Royal Bank Of Scotland
Royal Dutch Shell
RTL Group
RTL Group
S&P 500
Samas Groep
Sapec
SBM Offshore
Scandinavische (Noorse, Zweedse, Deense, Finse) aandelen
Schuitema
Seagull
Sequana Medical
Shurgard
Siemens Gamesa
Sif Holding
Signify
Simac
Sioen Industries
Sipef
Sligro Food Group
SMA Solar technology
Smartphoto Group
Smit Internationale
Snowworld
SNS Fundcoach Beleggingsfondsen Competitie
SNS Reaal
SNS Small & Midcap Competitie
Sofina
Softimat
Solocal Group
Solvac
Solvay
Sopheon
Spadel
Sparen voor later
Spectra7 Microsystems
Spotify
Spyker N.V.
Stellantis
Stellantis
Stern
Stork
Sucraf A en B
Sunrun
Super de Boer
SVK (Scheerders van Kerchove)
Syensqo
Systeem Trading
Taiwan Semiconductor Manufacturing Company (TSMC)
Technicolor
Tele Atlas
Telegraaf Media
Telenet Groep Holding
Tencent Holdings Ltd
Tesla Motors Inc.
Tessenderlo Group
Tetragon Financial Group
Teva Pharmaceutical Industries
Texaf
Theon International
TherapeuticsMD
Thunderbird Resorts
TIE
Tigenix
Tikkurila
TINC
TITAN CEMENT INTERNATIONAL
TKH Group
TMC
TNT Express
TomTom
Transocean
Trigano
Tubize
Turbo's
Twilio
UCB
Umicore
Unibail-Rodamco
Unifiedpost
Unilever
Unilever
uniQure
Unit 4 Agresso
Univar
Universal Music Group
USG People
Vallourec
Value8
Value8 Cum Pref
Van de Velde
Van Lanschot
Vastned
Vastned Retail Belgium
Vedior
VendexKBB
VEON
Vermogensbeheer
Versatel
VESTAS WIND SYSTEMS
VGP
Via Net.Works
Viohalco
Vivendi
Vivoryon Therapeutics
VNU
VolkerWessels
Volkswagen
Volta Finance
Vonovia
Vopak
Warehouses
Wave Life Sciences Ltd
Wavin
WDP
Wegener
Weibo Corp
Wereldhave
Wereldhave Belgium
Wessanen
What's Cooking
Wolters Kluwer
X-FAB
Xebec
Xeikon
Xior
Yatra Capital Limited
Zalando
Zenitel
Zénobe Gramme
Ziggo
Zilver - Silver World Spot (USD)
Indices
AEX
881,78
+0,30%
EUR/USD
1,0772
-0,16%
FTSE 100
7.952,62
+0,26%
Germany40^
18.505,40
+0,15%
Gold spot
2.234,24
0,00%
NY-Nasdaq Composite
16.379,46
-0,12%
Stijgers
Dalers